• #1154975
  • 625
  • Seqirus USA Inc #33332032001

Afluria® Quadrivalent 2020 - 2021 Flu Vaccine 60 mcg Indicated For People 3 Years of Age and Above Prefilled Syringe 5 mL

AFLURIA 2020, QUAD SYR 5ML (10DOSE/BX)

Features
  • AFLURIA QUADRIVALENT is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
  • AFLURIA QUADRIVALENT is approved for use in persons 3 Years of age and older
  • AFLURIA QUADRIVALENT is standardized according to USPHS requirements for the 2020 - 2021 influenza season and is formulated to contain 60 mcg hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg HA for each of the four influenza strains recommended for the 2020 - 2021 Northern Hemisphere influenza season:
  • More …
  Log In to Order
or

Professionals Also Viewed


Product Specifications


McKesson #1154975
Manufacturer #33332032001
BrandAfluria® Quadrivalent 2020 - 2021
ManufacturerSeqirus USA Inc
Country of OriginAustralia
ApplicationFlu Vaccine
Container TypePrefilled Syringe
Dosage FormInjection
NDC Number33332-0320-01
Product DatingMcKesson Acceptable Dating: we will ship >= 180 days
Storage RequirementsRequires Refrigeration
Strength60 mcg
TypeIntramuscular
UNSPSC Code51201608
UserIndicated For People 3 Years of Age and Above
Volume5 mL
Features
  • AFLURIA QUADRIVALENT is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
  • AFLURIA QUADRIVALENT is approved for use in persons 3 Years of age and older
  • AFLURIA QUADRIVALENT is standardized according to USPHS requirements for the 2020 - 2021 influenza season and is formulated to contain 60 mcg hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg HA for each of the four influenza strains recommended for the 2020 - 2021 Northern Hemisphere influenza season:
  • A/Brisbane/02/2018 (IVR-190) (an A/Brisbane/02/2018 (H1N1)pdm09 – like virus), A/Kansas/14/2017 (X-327) (an A/Kansas/14/2017 (H3N2) – like virus), B/Maryland/15/2016 (a B/Colorado/06/2017 – like virus) and B/Phuket/3073/2013 BVR-1B (a B/Phuket/3073/2013 – like virus). A 0.25 mL dose contains 7.5 mcg HA of each of the same four influenza strains.